Australia markets closed

Shockwave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
328.87+0.33 (+0.10%)
At close: 04:00PM EDT
330.00 +1.13 (+0.34%)
After hours: 07:36PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.34B
Enterprise value 12.12B
Trailing P/E 85.42
Forward P/E 68.97
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.21
Price/book (mrq)18.45
Enterprise value/revenue 16.59
Enterprise value/EBITDA 63.25

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 314.31%
S&P500 52-week change 322.64%
52-week high 3331.58
52-week low 3157.00
50-day moving average 3289.17
200-day moving average 3231.44

Share statistics

Avg vol (3-month) 31.07M
Avg vol (10-day) 31.31M
Shares outstanding 537.51M
Implied shares outstanding 637.51M
Float 836.82M
% held by insiders 11.27%
% held by institutions 195.35%
Shares short (28 Mar 2024) 42.03M
Short ratio (28 Mar 2024) 42.97
Short % of float (28 Mar 2024) 47.07%
Short % of shares outstanding (28 Mar 2024) 45.43%
Shares short (prior month 29 Feb 2024) 41.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 20.17%
Operating margin (ttm)21.96%

Management effectiveness

Return on assets (ttm)9.38%
Return on equity (ttm)24.96%

Income statement

Revenue (ttm)730.23M
Revenue per share (ttm)19.89
Quarterly revenue growth (yoy)40.90%
Gross profit (ttm)N/A
EBITDA 176.35M
Net income avi to common (ttm)147.28M
Diluted EPS (ttm)3.85
Quarterly earnings growth (yoy)-68.60%

Balance sheet

Total cash (mrq)990.55M
Total cash per share (mrq)26.49
Total debt (mrq)770.61M
Total debt/equity (mrq)115.24%
Current ratio (mrq)11.76
Book value per share (mrq)18.08

Cash flow statement

Operating cash flow (ttm)196.05M
Levered free cash flow (ttm)112.47M